Chemistry: molecular biology and microbiology – Process of mutation – cell fusion – or genetic modification – Introduction of a polynucleotide molecule into or...
Reexamination Certificate
2001-05-08
2008-07-22
Yu, Misook (Department: 1642)
Chemistry: molecular biology and microbiology
Process of mutation, cell fusion, or genetic modification
Introduction of a polynucleotide molecule into or...
C514S04400A
Reexamination Certificate
active
07402434
ABSTRACT:
The invention relates to methods and reagents for influencing alternative RNA splicing in living cells. More particularly, the invention relates to novel means for influencing RNA splice choice in living cells using polynucleotide-based reagents that compete for binding sites in nucleotide binding proteins, and novel methods for using these reagents as therapeutics.
REFERENCES:
Blanchette et al (Apr. 1, 1999, The EMBO Journal, vol. 18, pp. 1939-1952).
McNally et al (Mar. 1999, Journal of Virology, vol. 73, pp. 2385-2393).
Caceres et al (1998, Genes Dev., vol. 12, pp. 55-66).
Ross et al (1997, Molecular And Cellular Biology, vol. 17, pp. 2158-2165).
Muro et al (Mol Cell Biol. Apr. 1999;19(4):2657-71).
Hastings et al (J Biol Chem. Apr. 14, 2000;275(15):11507-13).
Maniatis and Tasic (2002, Nature, vol. 236, pp. 236-243).
Caputi et al., (1999, The EMBO Journal, vol. 18, pp. 4060-4067).
Purcell and Martin (J. Virol.,1993, vol. 67, pp. 6365-6378).
Damgaard et al., (2002, RNA, vol. 8, pp. 1401-1415.
Section 2. Virology (total 5 pages) of Medical Microbiology (S. Baron, ed) downloaded from url>>cbi.nlm.nih.gov/books on Apr. 20, 2004.
Lee et al., (Faseb J., 2000, vol. 14, pp. 516-522 abstract only).
Voet et al (Biochemistry, 1990, John Wiley & Sons, p. 856 only).
Sambrook et al (1989, Molecular Cloning, A Laboratory Manuel, 2nd Edition, pp. 16.30-16.33).
Bronstein Natalie B.
Newman Stuart A.
Kelley Drye & Warren LLP
Yu Misook
LandOfFree
Splice choice antagonists as therapeutic agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Splice choice antagonists as therapeutic agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Splice choice antagonists as therapeutic agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3964364